Related Experiment Video
Updated: Aug 7, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Clinical and epidemiological features of patients with chronic hepatitis C co-infected with HIV
Eduardo Lorens Braga1, André Castro Lyra, Fabrizio Ney-Oliveira
1Department of Medicine, Gastro-Hepatology Service, Federal University of Bahia, Salvador, BA, Brazil. elbraga@ig.com.br
Insights
Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection worsens chronic hepatitis C. Co-infected patients showed more severe liver disease and higher rates of genotype-2/3, emphasizing the need for Hepatitis B virus (HBV) immunization.
Area of Science:
- Hepatology
- Infectious Diseases
- Epidemiology
Background:
- Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection is a growing global health concern.
- Antiretroviral therapy has increased HIV-positive individuals' lifespan, potentially accelerating HCV-related liver disease progression.
- Understanding the interplay between HCV and HIV is crucial for managing chronic hepatitis C in co-infected populations.
Purpose of the Study:
- To investigate the clinical and epidemiological characteristics of patients with chronic hepatitis C co-infected with HIV.
- To analyze the impact of HIV co-infection on the progression of HCV-induced liver disease.
- To identify risk factors and specific HCV genotypes associated with co-infection.
Main Methods:
- A comparative study involving 134 HCV-infected patients, divided into 65 co-infected (HCV/HIV) and 69 mono-infected (HCV) groups.
- Assessment of liver disease severity using Child's score, ultrasound, and liver histology.
- HCV genotyping and anti-HBs (hepatitis B surface antibody) levels were determined for all participants.
Main Results:
- Co-infected patients exhibited a higher prevalence of severe liver disease (Child's score B or C) and ultrasound-diagnosed chronic liver disease.
- Injected drug use and homo/bisexual practices were significantly more common in the co-infected group.
- HCV genotypes 2/3 were more frequently observed in patients with HCV/HIV co-infection.
Conclusions:
- HIV co-infection appears to negatively influence the clinical progression of chronic hepatitis C.
- Specific risk factors like injected drug use and sexual practices, along with HCV genotype 2/3, are more prevalent in co-infected individuals.
- Routine immunization against Hepatitis B virus (HBV) is strongly recommended for patients with HCV/HIV co-infection.
Unlabelled:
Co-infection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) is increasingly common and affects the clinical course of chronic hepatitis C. Highly active antiretroviral therapy has improved the life expectancy of HIV infected patients, but, by extending survival, it permits the development of HCV cirrhosis. This study tried to evaluate clinical and epidemiological features of patients with chronic hepatitis C co-infected with HIV. We evaluated 134 HCV-infected patients: i) group A-- 65 co-infected HCV/HIV patients, ii) group B-- 69 mono-infected HCV patients. The impact of HIV infection on HCV liver disease was analyzed using Child's score, ultrasound findings and liver histology. Patients were subjected to HCV genotyping and anti-HBs dosage. Patients mean age was 42.4 years (+/-9.1) and 97 (72.4%) were males. Injected drug use and homo/bisexual practice were more frequently encountered in the co-infected group: 68.3% and 78.0%, respectively. Antibodies against hepatitis B virus (anti-HBs) were found in only 38.1% of the patients (66.7% group A x 33.3% group B). Ten out of 14 individuals (71.4%) who had liver disease (Child B or C) and 25 out of 34 (73.5%) who showed ultrasound evidence of chronic liver disease were in the co-infection group. HCV genotype-2/3 was more frequently encountered in co-infected patients (36.9% group A vs. 21.8% group B).
Conclusions:
a) HIV infection seems to adversely affect the clinical course of chronic hepatitis C, b) injected drug use, bi/homosexual practice and genotype-2/3 were more frequently encountered in co-infected patients, c) immunization against HBV should be encouraged in these patients.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Retrovirus Life Cycles
Chronic Kidney Disease II: Clinical Manifestations
Cryptococcal Meningitis
Cytomegalovirus Disease